메뉴 건너뛰기




Volumn 8, Issue 8, 2009, Pages 751-755

The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: A Scholtz-Dumas bioassay comparison

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL; CLOBETASOL PROPIONATE; FLUOCINONIDE; PLACEBO; ULOBETASOL PROPIONATE; DERMATOLOGICAL AGENT; DRUG DERIVATIVE; GLUCOCORTICOID; HALOBETASOL;

EID: 70349250336     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (11)

References (20)
  • 1
    • 84872205037 scopus 로고    scopus 로고
    • Available at: Accessed 05 September 2007
    • National Psoriasis Foundation. About psoriasis. Available at: http://www.psoriasis.org/about/faq. Accessed 05 September 2007.
    • About Psoriasis
  • 3
    • 14244258610 scopus 로고    scopus 로고
    • Psoriasis pathophysiology: Current concepts of pathogenesis
    • Krueger JG, Bowcock A. Psoriasis pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis. 2005;64:ii30-ii36.
    • (2005) Ann Rheum Dis , vol.64
    • Krueger, J.G.1    Bowcock, A.2
  • 4
    • 25444469167 scopus 로고    scopus 로고
    • Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis
    • DOI 10.1080/09546630510041060
    • Lowe N, Feldman SR, Sherer D, et al. Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis. J Dermatolog Treat. 2005;16(3):158-164. (Pubitemid 41364775)
    • (2005) Journal of Dermatological Treatment , vol.16 , Issue.3 , pp. 158-164
    • Lowe, N.1    Feldman, S.R.2    Sherer, D.3    Weiss, J.4    Shavin, J.S.5    Lin, Y.L.6    Foley, V.7    Soto, P.8
  • 5
    • 80053006170 scopus 로고    scopus 로고
    • Available at Accessed 26 September 2007
    • Temovate prescribing information. Available at: http://www.pharmaderm. com/pdf/Temovate-pi-cream.pdf. Accessed 26 September 2007.
    • Temovate Prescribing Information
  • 6
    • 80052994987 scopus 로고    scopus 로고
    • Available at Accessed 26 September 2007
    • Ultravate prescribing information. Available at: http://packageinserts. bms.com/pi/pi-ultravate-cream.pdf. Accessed 26 September 2007.
    • Ultravate Prescribing Information
  • 7
    • 80053016688 scopus 로고    scopus 로고
    • Available at: Accessed 26 September 2007
    • Vanos prescribing information. Available at: http://www.medicis.com/ products/pi/pi-vanos.pdf. Accessed 26 September 2007.
    • Vanos Prescribing Information
  • 8
    • 25144518209 scopus 로고    scopus 로고
    • Vanos (fluocinonide cream, 0.1%)
    • Abramovits W, Gupta AK. Vanos (fluocinonide cream, 0.1%). Skinmed. 2005;4:239-240.
    • (2005) Skinmed , vol.4 , pp. 239-240
    • Abramovits, W.1    Gupta, A.K.2
  • 9
    • 0033021230 scopus 로고    scopus 로고
    • Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin
    • DOI 10.1023/A:1018890422825
    • Schwarb FP, Imanidis G, Smith EW, et al. Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin. Pharm Res. 1999;16(6):909-915. (Pubitemid 29284204)
    • (1999) Pharmaceutical Research , vol.16 , Issue.6 , pp. 909-915
    • Schwarb, F.P.1    Imanidis, G.2    Smith, E.W.3    Haigh, J.M.4    Surber, C.5
  • 10
    • 33845691405 scopus 로고    scopus 로고
    • An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis
    • DOI 10.1001/archderm.142.12.1568
    • Schlessinger J, Miller B, Gilbert RD, et al. An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis. Arch Dermatol. 2006;142(12):1568-1572. (Pubitemid 44969212)
    • (2006) Archives of Dermatology , vol.142 , Issue.12 , pp. 1568-1572
    • Schlessinger, J.1    Miller, B.2    Gilbert, R.D.3    Plott, R.T.4
  • 11
    • 0021932112 scopus 로고
    • Clobetasol propionate versus fluocinonide creams in psoriasis and eczema
    • Jegasothy B, Jacobson C, Levine N, et al. Clobetasol propionate versus fluocinonide creams in psoriasis and eczema. Int J Dermatol. 1985;24(7):461-465. (Pubitemid 15246727)
    • (1985) International Journal of Dermatology , vol.24 , Issue.7 , pp. 461-465
    • Jegasothy, B.1    Jacobson, C.2    Levine, N.3
  • 13
    • 0034959697 scopus 로고    scopus 로고
    • Calcipotriol ointment: A review of its use in the management of psoriasis
    • Scott LJ, Dunn CJ, Goa KL. Calcipotriol ointment. A review of its use in the management of psoriasis. Am J Clin Dermatol. 2001;2(2):95-120. (Pubitemid 32592528)
    • (2001) American Journal of Clinical Dermatology , vol.2 , Issue.2 , pp. 95-120
    • Scott, L.J.1    Dunn, C.J.2    Goa, K.L.3
  • 14
    • 0030076244 scopus 로고    scopus 로고
    • Comparison of cosmetic and physicochemical properties of six topical corticosteroid creams
    • Hadzija BW, Ambrose WW. Comparison of cosmetic and physicochemical properties of six topical corticosteroid creams. Cutis. 1996;57(2 Suppl):13-8.
    • (1996) Cutis , vol.57 , Issue.2 SUPPL. , pp. 13-18
    • Hadzija, B.W.1    Ambrose, W.W.2
  • 15
    • 42949094755 scopus 로고    scopus 로고
    • In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle
    • Gans EH, Sadiq I, Stoudemayer T, et al. In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle. J Drugs Dermatol. 2008;7(1):28-32.
    • (2008) J Drugs Dermatol , vol.7 , Issue.1 , pp. 28-32
    • Gans, E.H.1    Sadiq, I.2    Stoudemayer, T.3
  • 16
    • 0015265248 scopus 로고
    • The psoriasis bioassay for topical corticosteroid activity
    • Dumas KJ, Scholtz JR. The psoriasis bioassay for topical corticosteroid activity. Acta Derm Venereol. 1972;52(1):43-48.
    • (1972) Acta Derm Venereol , vol.52 , Issue.1 , pp. 43-48
    • Dumas, K.J.1    Scholtz, J.R.2
  • 18
    • 0001861697 scopus 로고    scopus 로고
    • Chapter 242: Principles of Topical Therapy
    • Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz S, eds. 5th Ed. New York, NY:McGraw-Hill
    • Shupack JL, Washenik K, Pak GH. Chapter 242: Principles of Topical Therapy. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz S, eds. Fitzpatrick's Dermatology in General Medicine. 5th Ed. New York, NY:McGraw-Hill; 1999:2702-2712.
    • (1999) Fitzpatrick's Dermatology in General Medicine , pp. 2702-2712
    • Shupack, J.L.1    Washenik, K.2    Pak, G.H.3
  • 19
    • 34247565553 scopus 로고    scopus 로고
    • The effect of adhesive dressing edges on cutaneous irritancy and skin barrier function
    • Dykes PJ. The effect of adhesive dressing edges on cutaneous irritancy and skin barrier function. J Wound Care. 2007;16(3):97-100.
    • (2007) J Wound Care , vol.16 , Issue.3 , pp. 97-100
    • Dykes, P.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.